Washington SB 5822: Concerning insurance coverage for biomarker testing.

Status: Scheduled for public hearing in the Senate Committee on Health & Long Term Care at 08:00 AM (as of 2022-01-28)

State: Washington · Session: 2021-2022 · Bill: SB 5822

Subjects: HEALTH CARE, INSURANCE

Sponsors: L. Wilson, Brown, Dozier, Frockt, Hasegawa, Stanford, Warnick

View Washington SB 5822 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.